High-grade gliomas, including glioblastoma and diffuse midline glioma are the most common malignant brain tumor types and leading causes of brain-tumor-related death in adults and children, respectively.
Stanford researchers have developed a mouth-cooling device that prevents or reduces the degree of oral mucositis (OM), a painful side effect of chemotherapy, radiotherapy, autoimmune conditions, and infections.
Oral mucositis (OM) is a painful side effect of chemoradiotherapy, especially in children and adolescents, with a high incidence rate of over 20%-40% and up to 90% in high risk patients.
Necrotizing enterocolitis is a life-threatening illness almost exclusively affecting the gastrointestinal tract of neonates. It's caused by bacterial invasion of the intestinal wall, which leads to inflammation and cellular destruction of the wall of the intestine.
Researchers at Stanford University have developed a software that applies correction algorithms on sequence data from cell-free DNA (cfDNA) in blood samples to estimate total T and B cell counts.
Pluripotent stem cells (PSCs) arise during early embryogenesis and can give rise to entire animals. Yet, comprehension of pluripotency regulation remains incomplete, highly species-specific, and primarily limited to mouse and human.
Stanford researchers have developed a novel CRISPR-based method, Oligo-LiveFISH, for generating large-scale pools of synthetic RNA oligos that enable multiplexed targeting, imaging, and manipulation of genomic regions in living cells.
Stanford scientists have discovered that Guanidinylated Serinol Charge-altering Releasable Transporters (GSer-CARTs) can be tuned for selective mRNA delivery to the lung and spleen in a predictable fashion.
Stanford researchers have developed a new method for producing high-quality lead-germanium-selenide (PbGeSe) thin films with improved optical performance and uniformity.
Stanford scientists have developed a frequency-based power control method that enables RF amplifiers to double their output power within 500 nanoseconds using only passive components.
The Stanford team developed a versatile injectable alginate-collagen hydrogel, a significant advancement in regenerative medicine and targeted therapeutic delivery.
Stanford scientists have discovered a DNA methylation signature on circulating tumor DNA (ctDNA) that can distinguish between the aggressive Leiomyosarcoma (LMS) from its benign counterpart leiomyoma (LM) in the uterus.